Appointment reflects Glauconix Biosciences' commitment to business and organizational excellence as they continue on their trajectory to become the leading developer of ex vivo-like 3D human tissue models for accelerating therapeutic innovation and drug discovery

Appointment reflects Glauconix Biosciences' stage of high growth and innovation in the field of ophthalmology

Study confirms intraocular pressure-lowering effects of cannabinoid-based therapeutic, proving promising novel treatment for glaucoma